Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 50: 1618-1622, 2004. First published June 17, 2004; 10.1373/clinchem.2004.036004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
clinchem.2004.036004v1
50/9/1618    most recent
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ajani, U. A.
Right arrow Articles by Mokdad, A. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ajani, U. A.
Right arrow Articles by Mokdad, A. H.
Related Collections
Right arrow Lipids, Lipoproteins, and Cardiovascular Risk Factors
(Clinical Chemistry. 2004;50:1618-1622.)
© 2004 American Association for Clinical Chemistry, Inc.

Lipids, Lipoproteins, and Cardiovascular Risk Factors

Prevalence of High C-Reactive Protein in Persons with Serum Lipid Concentrations within Recommended Values

Umed A. Ajania, Earl S. Ford and Ali H. Mokdad

1 Department of Adult and Community Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA.

aAddress correspondence to this author at: Centers for Disease Control and Prevention, 4770 Buford Hwy. NE, Mailstop K-66, Atlanta, GA 30341. Fax 770-488-8150; e-mail uajani{at}cdc.gov.

Background: C-Reactive protein (CRP) has been shown to be a strong predictor of coronary heart disease (CHD) and is being considered in cardiovascular disease risk assessment. The number of normolipidemic individuals who are eligible for evaluation of CRP in overall CHD risk assessment is not known.

Methods: We analyzed data from the National Health and Nutrition Examination Survey 1999–2000 and computed the prevalence of high CRP (>3 mg/L) among normolipidemic adults. We also computed the prevalence among individuals free of CHD and diabetes. In addition, we examined the prevalence stratified by body mass index.

Results: The prevalence of high CRP among those with lipid concentrations within recommended values ranged from 28.8% to 35.3%, depending on the lipid fraction examined. Exclusion of individuals with CHD or diabetes and those with CRP concentrations >10 mg/L reduced the prevalence range (23.1–27.1%). Prevalence increased with increasing body mass index.

Conclusions: In 2000, ~12 million adults in the United States considered normolipidemic had high CRP concentrations. Additional studies to explore the role of CRP in cardiovascular disease risk assessment are needed.




The following articles in journals at HighWire Press have cited this article:


Home page
 CirculationHome page
I. S. Anand, R. Latini, V. G. Florea, M. A. Kuskowski, T. Rector, S. Masson, S. Signorini, P. Mocarelli, A. Hester, R. Glazer, et al.
C-Reactive Protein in Heart Failure: Prognostic Value and the Effect of Valsartan
Circulation, September 6, 2005; 112(10): 1428 - 1434.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American Association for Clinical Chemistry.